# Singmed opens Asia's largest inhaler production base in Changshu, China

Singmed Medical Device Science and Technology opened a CNY500 million (USD70 million) inhaler production base in Changshu, Jiangsu province, with an annual capacity of 50 million nebulizers.

- Type: New facility
- Announced: 2024-08-06
- Where: Changshu, Jiangsu province, China
- Value: $70.0M (500.0M CNY)
- Starts operating: 6 Aug 2024
- Status: completed
- Capacity: 50 million nebulizers per year
- Products: dry powdered inhalers, soft mist inhalers, nebulizers
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Singmed Medical Device Science and Technology](https://endata.com/companies/79052.md)

## Sources

- [yicaiglobal.com](https://www.yicaiglobal.com/news/suzhou-singmed-medical-device-finishes-building-of-asias-biggest-facility-for-drug-delivering-nebulizers), 2024-08-07: "Inhalers are one of the keys to the development of homegrown inhaled medication."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.